The clinically isolated syndrome (CIS) market is driven by increasing cases of neurological disorders. Clinically isolated syndrome is an early, one-time neurological episode in a person who is determined to be at high risk of developing multiple sclerosis. CIS products like biomarkers and tests are used for early diagnosis, treatment, and monitoring of MS. The global CIS market is witnessing significant growth due to growing awareness about early diagnosis and management of MS.
The clinically isolated syndrome (CIS) market is estimated to be valued at USD 16.03 Bn in 2024 and is expected to reach USD 25.19 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.
The Clinically Isolated Syndrome Market is expanding globally due to rising funding for MS research, increasing healthcare expenditures, and growing accessibility of diagnostic tests across developing nations.
Get More Insights - Clinically Isolated Syndrome Market
Get this Report in Japanese Language: 臨床的に孤立した症候群市場
Get this Report in Korean Language: 임상적으로 고립된 증후군 시장
Explore More Related Topics on - The Premium Sleep Experience: Exploring the World of Luxury Bedding in the UK
